The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
20-Jan-21
$1.9 billion
Target:
Extraction Oil and Gas
Acquiror:
N/A
Advised the Official Committee of Unsecured Creditors on the in-court restructuring of Extraction Oil and Gas, Inc., an Exploration and Production company focused on the Wattenberg Field of the Denver-Julesburg Basin
15-Jan-21
Undisclosed
Target:
Primus Telecommunications – Subsidiary of Fusion Connect, Inc.
Acquiror:
Distributel Communications Ltd.
Advising Fusion Connect, a telecommunications services provider, on the sale of its Canadian subsidiary, Primus Telecommunications, to Distributel Communications Ltd.
31-Dec-20
$1.2 billion
Target:
Pacific Drilling
Acquiror:
N/A
Advised Pacific Drilling, an international provider of offshore drilling services, on its pre-arranged Chapter 11 restructuring
29-Dec-20
$110 million
Target:
Biogix, Inc.
Acquiror:
Alliance Pharma plc
Advised Biogix, Inc., a leader in the development, research and distribution of clinically tested menopause and perimenopause supplements in the U.S. under the flagship brand Amberen, on its sale to Alliance Pharma plc
24-Nov-20
$1.5 billion
Target:
Cirque du Soleil
Acquiror:
Ad Hoc Group of Lenders
Advised the Company on its CCAA and Ch.15 proceedings and $1.5bn sale through a Sale and Investment Solicitation Process (SISP)
20-Nov-20
Undisclosed
Target:
Vorboss Limited
Acquiror:
Fern Fibre Limited (Advised by Octopus Investments)
Advised Vorboss Limited, a London-based fibre operator, on its sale to Fern Fibre Limited / Octopus Investments, securing a funding commitment enabling an ambitious fibre deployment program
19-Nov-20
$797 million
Target:
iQor Holdings Inc.
Acquiror:
N/A
Advised the ad-hoc Cross-Holder Group of lenders on the fully consensual Prepackaged Plan of Reorganization of iQor Holdings Inc., a business process outsourcing company
17-Nov-20
$497 million
Target:
Gannett Co., Inc.
Acquiror:
N/A
Advised Gannett Co., Inc., a news media and marketing solutions company, on the refinancing of ~$500mm of its term loan with convertible notes
19-Oct-20
$546 million
Target:
Learning Materials for the K-12 Segment in Spain
Acquiror:
Sanoma Oyj
Advising Sanoma Oyj (HEL: SAA1V), a European learning and media company listed on Nasdaq Helsinki, on the acquisition of Santillana Spain, a leading Spanish provider of K-12 learning materials, from Promotora de Informaciones S.A. (Grupo Prisa, BME: PRS)
13-Oct-20
Pending
Undisclosed
Target:
Axión Group
Acquiror:
Asterion Industrial Partners
Advised AMP Capital on the sale of its portfolio company Axión Group, a leading independent broadcasting and telecommunications infrastructure provider in Spain, to Asterion Industrial Partners, a Spanish infrastructure fund
04-Oct-20
Undisclosed
Target:
Cosmetic applications endolysin
Acquiror:
L’Oréal
Advised Micreos, a fast-growing biotechnology company, on a long-term license agreement with L’Oréal for one of Micreos’ phage-based active ingredients, SA.100
01-Oct-20
$1.05 billion
Target:
Akorn, Inc.
Acquiror:
First Lien Term Loan Lenders
Advised Ad Hoc Group of First Lien Term Loan Lenders on Akorn’s in-court recapitalization
22-Sep-20
$NA
Target:
VX Fiber
Acquiror:
AMP Capital
Advised VX Fiber, an international infrastructure and technology business focused on Fibre-to-the-Home networks, on its sale to the infrastructure fund AMP Capital
15-Sep-20
$NA
Target:
Surgery Partners’ Anesthesia Services
Acquiror:
NorthStar Anesthesia
Advised Surgery Partners, a leading owner and operator of surgical facilities, on the divestiture of its anesthesia services business to NorthStar Anesthesia
03-Sep-20
$789 million
Target:
Unit Corporation
Acquiror:
N/A
Advised the Ad Hoc Group of Noteholders on the prepackaged in-court restructuring of Unit Corporation
12-Aug-20
$225 million
Target:
340B Link
Acquiror:
Omnicell
Advising Omnicell, a leading provider of medication management solutions and adherence tools for health systems and pharmacies, on the acquisition of the 340B Link business from Pharmaceutical Strategies Group (PSG)
03-Aug-20
$335 million
Target:
Range Resources Terryville Assets
Acquiror:
Castleton Resources, LLC
Advised Castleton Resources, a Houston, TX based, privately held oil and gas operator, on its acquisition of Range Resources’ Terryville Assets. As part of the transaction, Castleton Resources will change its name to “TG Natural Resources LLC” by late March 2021. Range Resources (NYSE: RRC) is a Fort Worth, TX based E&P company with primary operations in the Marcellus Shale formation.
29-Jul-20
$NA
Target:
Community Fibre Limited
Acquiror:
Warburg Pincus LLC, Deutsche Telekom Capital Partners
Advised Warburg Pincus LLC and Deutsche Telekom Capital Partners on the acquisition of a majority stake in CommunityFibre Limited, a leading full fibre network infrastructure platform in UK
01-Jul-20
$22 billion
Target:
PG&E Corporation
Acquiror:
N / A
Advised Pension Benefit Guaranty Corporation (“PBGC”) in connection with PG&E’s in-court restructuring
01-Jul-20
$225 million
Target:
Cello Health plc
Acquiror:
Arsenal Capital Partners
Advised Cello Health, a global healthcare-focused advisory firm, on a recommended cash offer for its entire issued share capital from Arsenal Capital Partners, a specialised private equity firm based in the United States
10-Jun-20
$134 million
Target:
Equity stake in Bupa Arabia
Acquiror:
Bupa Ltd.
Advising Bupa, a leading international healthcare group, on the increase of its stake in Bupa Arabia, the largest health insurance provider in the Kingdom of Saudi Arabia
10-Jun-20
$3.9 billion
Target:
Global collaboration agreement with Genmab A/S
Acquiror:
AbbVie, Inc
Advised AbbVie, Inc, an NYSE-listed global biopharmaceutical company, on a broad collaboration with Genmab A/S, a leading Danish-listed biotechnology company, to jointly develop and commercialise three next-generation bispecific antibody programs
03-Jun-20
$NA
Target:
Cerner RevWorks
Acquiror:
R1 RCM
Advised Cerner Corporation, a leader in healthcare information technology, on its sale of its RevWorks revenue cycle management services business to R1 RCM, a leading provider of technology-enabled RCM services
23-Mar-20
$68 million
Target:
Abacus Health Products, Inc.
Acquiror:
Charlotte’s Web Holdings, Inc.
Advised Abacus Health Products, Inc., a leader in over-the-counter (“OTC”) topical products combining active pharmaceutical ingredients with cannabidiol (“CBD”) hemp extract, on its sale to the Charlotte’s Web Holdings, Inc., a market leader in hemp-derived CBD wellness products.
18-Mar-20
$NA
Target:
Centrifuge and processing equipment business of Koki Holdings Co., Ltd.
Acquiror:
Eppendorf AG
Advised Eppendorf AG, a leading family-owned life science company, on the acquisition of the centrifuge and processing equipment business of KKR-owned Koki Holdings Co., Ltd., a manufacturer of power tools and centrifuge and processing equipment